MGS, a US-based healthcare packaging manufacturer, is leveraging KraussMaffei’s advanced injection molding expertise to drive global growth. A cornerstone of this collaboration is the deployment of all-electric PX machines equipped with integrated LRX linear robots in a specialized medical configuration.

These cleanroom-compatible machines feature an automatic centralized lubrication system within a closed circuit, making the platform ideal for ISO Class 8 cleanroom manufacturing environments.

All-electric PX injection molding machines from KraussMaffei equipped with LRX linear robots in production at MGS in Richfield. (Photo: MGS)

As many MGS programs utilize high-cavity molds with demanding cycle times, absolute repeatability across every cavity is critical. Manufacturing low-weight medical components, such as laboratory consumables, requires both precision hot runner technology and injection molding machines that ensure a completely constant shot weight.

KraussMaffei addresses this challenge with its intelligent APCplus process control function. This digital solution optimally adjusts the switching point and holding pressure from shot to shot to match the respective melt viscosity.

Beyond technical precision, KraussMaffei provides the agility required to scale high-stakes medtech programs. During rapid product launches, the KraussMaffei team has consistently supported MGS by delivering and commissioning multiple machines on accelerated timelines.

MGS Richfield Facility.

Supporting the A.i.r. Platform

This collaborative manufacturing foundation is critical as MGS drives further growth with its proprietary A.i.r. Platform (Auto-injector reimagined). Built around a fully certified internal mechanism, the platform provides pharmaceutical clients with a proven, ready-to-use system.

The system allows the external design and user interface to be customized to meet specific brand, therapeutic, and patient requirements. This approach significantly compresses development timelines, mitigates technical risk, and streamlines the regulatory approval process for a faster market launch.

To support the growing global demand for the A.i.r. Platform, MGS relies on the high-level technical support, operational responsiveness, and long-standing partnership that KraussMaffei provides.